A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Автор: | Sorno, Rubina Haque |
---|---|
Інші автори: | Khair, Nishat Zareen |
Формат: | Дисертація |
Мова: | English |
Опубліковано: |
Brac University
2024
|
Предмети: | |
Онлайн доступ: | http://hdl.handle.net/10361/23842 |
Схожі ресурси
-
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
за авторством: Flora, Sanzida Alam
Опубліковано: (2024) -
A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
за авторством: Khan, Muidul Hasan
Опубліковано: (2024) -
In silico modelling and structural dynamics of PSY1R kinase domain and its interaction with SERK1 kinase
за авторством: Ruhee, Noshin Nawer
Опубліковано: (2022) -
Arresting tumor cell proliferation and inhibition of AKT pathway via the use of multikinase inhibitor sorafenib forthe treatment of glioblastoma
за авторством: Raju, Md. Ismail
Опубліковано: (2022) -
A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
за авторством: Ratu, Tabassum
Опубліковано: (2024)